Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation [Phase 2]
A Phase 2 clinical trial by Biogen is evaluating felzartamab infusions in adults with kidney transplants who have late isolated microvascula…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: The smartNTx Trial:Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR) [NA]
The smartNTx trial is evaluating telemedical management versus standard aftercare in kidney transplant recipients; the study is currently ac…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized [Phase 2]
Phase 2 study evaluating Belimumab to mobilize memory B-cells and improve HLA-specificity profiling for delisting to access transplanted kid…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
Phase 3 study to assess long-term safety and effects of felzartamab infusions in adults with antibody-mediated rejection after kidney transp…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients [Phase 3]
Phase 3 clinical trial investigating treatment of BK polyomavirus infection in kidney and simultaneous kidney-pancreas transplant recipients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing frexalimab to tacrolimus in adults undergoing kidney transplantation is currently recruiting to assess eff…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
A recruiting clinical study evaluating peripheral and intrarenal B cells in antibody-mediated rejection after kidney transplantation, focusi…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Trifecta-Kidney cfDNA-MMDx Study
A University of Alberta-led clinical trial is currently recruiting to evaluate the trifecta-kidney cfDNA-MMDx diagnostic approach for kidney…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) [Phase 3]
A Phase 3 study is evaluating the safety and effects of felzartamab infusions in adults with antibody-mediated rejection after kidney transp…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Treatment of Antibody-Mediated Rejection (ABMR) With CarBel [Phase 2]
Phase 2 clinical trial evaluating CarBel for treating antibody-mediated rejection in kidney transplant recipients; currently not yet recruit…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: (TNX-1500) in Kidney Transplant Recipients [Phase 2]
A Phase 2 clinical trial update for TNX-1500 in kidney transplant recipients, with the study status listed as NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Torque Teno Virus: A Biomarker of Immunosuppression
An update on a completed clinical trial evaluating Torque Teno Virus as a biomarker of immunosuppression in kidney transplant recipients, wi…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA
A clinical trial is evaluating urinary CXCL10 as a biomarker to improve detection of acute kidney allograft rejection in kidney transplant p…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R) [Phase 2, Phase 3]
A Phase 2/3 clinical trial (BELA-M-R) is evaluating belatacept for prevention of subclinical antibody-mediated rejection after kidney transp…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab [NA]
The document reports that a clinical trial evaluating tocilizumab for chronic active antibody-mediated rejection in kidney transplant patien…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Using MSCs for Chronic Active Antibody Mediated Rejection [NA]
A clinical trial entry evaluating mesenchymal stem cell therapy for chronic active antibody-mediated rejection in kidney transplant recipien…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection
An observational study in Scotland led by the University of Edinburgh to identify predictors and improve diagnosis of kidney transplant reje…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS
This clinical trial update reports transcriptional profiling of peripheral blood cells in a patient with kidney and lung graft rejection and…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Blood Biomarkers in Pediatric Kidney Transplant Recipients
This clinical trial investigates blood biomarkers in pediatric kidney transplant recipients to monitor rejection. The study is currently act…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients [Phase 2]
Clinical trial update indicates Tegoprubart is being studied in Phase 2 for long-term safety and efficacy in kidney transplant recipients, w…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Platelet Aggregation in the Diagnosis of Acute Graft Rejection
A recruiting clinical trial evaluating whether platelet aggregation can aid in diagnosing acute kidney transplant rejection.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants [Phase 1]
Phase 1 clinical trial evaluating delayed immunological tolerance in well-functioning, HLA-matched kidney transplant recipients; currently r…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
This document provides an update on Verici Dx’s clinical trial validating genomic immune-phenotyping profiles to predict the risk of kidney …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
This study is validating donor-derived cell-free DNA as a noninvasive biomarker to monitor kidney transplant rejection and is currently recr…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)
This document provides an update on the PIONEER trial evaluating the post-transplant use of TruGraf and TRAC Molecular Panel in renal transp…